A Spatio-Temporal Analysis of Matrix Protein and Nucleocapsid Trafficking during Vesicular Stomatitis Virus Uncoating
To study VSV entry and the fate of incoming matrix (M) protein during virus uncoating we used recombinant viruses encoding M proteins with a C-terminal tetracysteine tag that could be fluorescently labeled using biarsenical (Lumio) compounds. We found that uncoating occurs early in the endocytic pathway and is inhibited by expression of dominant-negative (DN) Rab5, but is not inhibited by DN-Rab7 or DN-Rab11. Uncoating, as defined by the separation of nucleocapsids from M protein, occurred between 15 and 20 minutes post-entry and did not require microtubules or an intact actin cytoskeleton. Unexpectedly, the bulk of M protein remained associated with endosomal membranes after uncoating and was eventually trafficked to recycling endosomes. Another small, but significant fraction of M distributed to nuclear pore complexes, which was also not dependent on microtubules or polymerized actin. Quantification of fluorescence from high-resolution confocal micrographs indicated that after membrane fusion, M protein diffuses across the endosomal membrane with a concomitant increase in fluorescence from the Lumio label which occurred soon after the release of RNPs into the cytoplasm. These data support a new model for VSV uncoating in which RNPs are released from M which remains bound to the endosomal membrane rather than the dissociation of M protein from RNPs after release of the complex into the cytoplasm following membrane fusion.
Vyšlo v časopise:
A Spatio-Temporal Analysis of Matrix Protein and Nucleocapsid Trafficking during Vesicular Stomatitis Virus Uncoating. PLoS Pathog 6(7): e32767. doi:10.1371/journal.ppat.1000994
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000994
Souhrn
To study VSV entry and the fate of incoming matrix (M) protein during virus uncoating we used recombinant viruses encoding M proteins with a C-terminal tetracysteine tag that could be fluorescently labeled using biarsenical (Lumio) compounds. We found that uncoating occurs early in the endocytic pathway and is inhibited by expression of dominant-negative (DN) Rab5, but is not inhibited by DN-Rab7 or DN-Rab11. Uncoating, as defined by the separation of nucleocapsids from M protein, occurred between 15 and 20 minutes post-entry and did not require microtubules or an intact actin cytoskeleton. Unexpectedly, the bulk of M protein remained associated with endosomal membranes after uncoating and was eventually trafficked to recycling endosomes. Another small, but significant fraction of M distributed to nuclear pore complexes, which was also not dependent on microtubules or polymerized actin. Quantification of fluorescence from high-resolution confocal micrographs indicated that after membrane fusion, M protein diffuses across the endosomal membrane with a concomitant increase in fluorescence from the Lumio label which occurred soon after the release of RNPs into the cytoplasm. These data support a new model for VSV uncoating in which RNPs are released from M which remains bound to the endosomal membrane rather than the dissociation of M protein from RNPs after release of the complex into the cytoplasm following membrane fusion.
Zdroje
1. SieczkarskiSB
WhittakerGR
2005 Viral entry. Current Topics in Microbiology & Immunology 285 1 23
2. MarshM
HeleniusA
2006 Virus entry: open sesame. Cell 124 729 740
3. MatlinK
ReggioH
HeleniusA
SimonsK
1982 The pathway of vesicular stomatitis entry leading to infection. J Mol Biol 156 609 631
4. JohannsdottirHK
ManciniR
KartenbeckJ
AmatoL
HeleniusA
2009 Host cell factors and functions involved in vesicular stomatitis virus entry. J Virol 83 440 453
5. SieczkarskiSB
WhittakerGR
2003 Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4 333 343
6. CuretonDK
MassolRH
SaffarianS
KirchhausenTL
WhelanSP
2009 Vesicular stomatitis virus enters cells through vesicles incompletely coated with clathrin that depend upon actin for internalization. PLoS Pathog 5 e1000394
7. NewcombWW
TobinGJ
McGowanJJ
BrownJC
1982 In vitro reassembly of vesicular stomatitis virus skeletons. J Virol 41 1055 1062
8. NewcombWW
BrownJC
1981 Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions. J Virol 39 295 299
9. GeP
TsaoJ
ScheinS
GreenTJ
LuoM
2010 Cryo-EM model of the bullet-shaped vesicular stomatitis virus. Science 327 689 693
10. RigautKD
BirkDE
LenardJ
1991 Intracellular distribution of input vesicular stomatitis virus proteins after uncoating. J Virol 65 2622 2628
11. Le BlancI
LuyetPP
PonsV
FergusonC
EmansN
2005 Endosome-to-cytosol transport of viral nucleocapsids. Nature Cell Biology 7 653 664
12. LuyetPP
FalguieresT
PonsV
PattnaikAK
GruenbergJ
2008 The ESCRT-I subunit TSG101 controls endosome-to-cytosol release of viral RNA. Traffic 9 2279 2290
13. LylesDS
McKenzieMO
1998 Reversible and irreversible steps in assembly and disassembly and vesicular stomatitis virus: equilibria and kinetics of dissociation of nucleocapsid-M protein complexes assembled in vivo. Biochemistry 37 439 450
14. ClintonGM
LittleSP
HagenFS
HuangAS
1978 The matrix (M) protein of vesicular stomatitis virus regulates transcription. Cell 15 1455 1462
15. WilsonT
LenardJ
1981 Interaction of wild-type and mutant M protein vesicular stomatitis virus with nucleocapsids in vitro. Biochemistry 20 1349 1354
16. DeBP
ThorntonGB
LukD
BanerjeeAK
1982 Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro. Proceedings of the National Academy of Sciences of the United States of America 79 7137 7141
17. MartinK
HeleniusA
1991 Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import. Cell 67 117 130
18. KemlerI
WhittakerG
HeleniusA
1994 Nuclear import of microinjected influenza virus ribonucleoproteins. Virology 202 1028 1033
19. MireCE
DubeD
DelosSE
WhiteJM
WhittMA
2009 Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein. J Virol 83 12139 12150
20. DasSC
PandaD
NayakD
PattnaikAK
2009 Biarsenical labeling of vesicular stomatitis virus encoding tetracysteine-tagged m protein allows dynamic imaging of m protein and virus uncoating in infected cells. J Virol 83 2611 2622
21. FengY
PressB
Wandinger-NessA
1995 Rab 7: an important regulator of late endocytic membrane traffic. Journal of Cell Biology 131 1435 1452
22. GruenbergJ
2001 The endocytic pathway: a mosaic of domains. Nature Reviews Molecular Cell Biology 2 721 730
23. MiaczynskaM
ZerialM
2002 Mosaic organization of the endocytic pathway. Experimental Cell Research 272 8 14
24. LefrancoisL
LylesDS
1982 The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. Virology 121 157 167
25. HeleniusA
MarshM
WhiteJ
1982 Inhibition of Semliki Forest virus penetration by lysosomotropic weak bases. J Gen Virol 58 47 61
26. FariaPA
ChakrabortyP
LevayA
BarberGN
EzelleHJ
2005 VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Molecular Cell 17 93 102
27. PetersenJM
HerLS
VarvelV
LundE
DahlbergJE
2000 The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol Cell Biol 20 8590 8601
28. DasSC
NayakD
ZhouY
PattnaikAK
2006 Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells. Journal of Virology 80 6368 6377
29. JeetendraE
RobisonCS
AlbrittonLM
WhittMA
2002 The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J Virol 76 12300 12311
30. HerLS
LundE
DahlbergJE
1997 Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276 1845 1848
31. BlondelD
HarmisonGG
SchubertM
1990 Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol 64 1716 1725
32. MelkiR
GaudinY
BlondelD
1994 Interaction between tubulin and the viral matrix protein of vesicular stomatitis virus: possible implications in the viral cytopathic effect. Virology 202 339 347
33. WongRW
BlobelG
CoutavasE
2006 Rae1 interaction with NuMA is required for bipolar spindle formation. Proceedings of the National Academy of Sciences of the United States of America 103 19783 19787
34. BlowerMD
NachuryM
HealdR
WeisK
2005 A Rae1-containing ribonucleoprotein complex is required for mitotic spindle assembly. Cell 121 223 234
35. FredericksenBL
WhittMA
1996 Mutations at two conserved acidic amino acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent conformational changes and reduce the pH threshold for membrane fusion. Virology 217 49 57
36. RocheS
BressanelliS
ReyFA
GaudinY
2006 Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science 313 187 191
37. WhiteJ
MatlinK
HeleniusA
1981 Cell fusion by Semliki Forest, influenza and vesicular stomatitis virus. J Cell Biol 89 674 679
38. BlumenthalR
Bali-PuriA
WalterA
CovellD
EidelmanO
1987 pH-dependent fusion of vesicular stomatitis virus with Vero cells. J Biol Chem 262 13614 13619
39. QuerbesW
O'HaraBA
WilliamsG
AtwoodWJ
2006 Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J Virol 80 9402 9413
40. SeachristJL
AnborghPH
FergusonSS
2000 beta 2-adrenergic receptor internalization, endosomal sorting, and plasma membrane recycling are regulated by rab GTPases. J Biol Chem 275 27221 27228
41. BucciC
ThomsenP
NicozianiP
McCarthyJ
van DeursB
2000 Rab7: a key to lysosome biogenesis. Mol Biol Cell 11 467 480
42. LapierreLA
DornMC
ZimmermanCF
NavarreJ
BurnetteJO
2003 Rab11b resides in a vesicular compartment distinct from Rab11a in parietal cells and other epithelial cells. Exp Cell Res 290 322 331
43. WangX
KumarR
NavarreJ
CasanovaJE
GoldenringJR
2000 Regulation of vesicle trafficking in Madin-Darby canine kidney cells by Rab11a and Rab25. J Biol Chem 275 29138 29146
44. GermanCL
HoweCL
2009 Preparation of biologically active subcellular fractions using the Balch homogenizer. Anal Biochem 394 117 124
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 7
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- RNA Virus Replication Complexes
- Virus-Infection or 5′ppp-RNA Activates Antiviral Signal through Redistribution of IPS-1 Mediated by MFN1
- Functional Genetic Diversity among Complex Clinical Isolates: Delineation of Conserved Core and Lineage-Specific Transcriptomes during Intracellular Survival
- Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites